Abstract:BACKGROUND:Cervical cancer is one of the most common gynecological malignancies. Cancer recurrence and the poor efficacy of cervical cancer treatments are mainly caused by invasion and metastasis of cervical cancer cells. This study is to investigate whether miR-29c-3p can inhibit epithelial-mesenchymal transition (EMT) by targeting secreted protein acidic and rich in cysteine (SPARC), thus inhibiting the invasion and metastasis of human cervical cancer cells.METHODS:The expression levels of miR-29c-3p and SPARC in cervical cancer tissues and non-tumor adjacent tissues, human normal cervical epithelial cell line Ect1/E6E7 and human cervical cancer cell lines HeLa, CaSki, C-33A, HT-3 and SiHa were detected. After the expression of miR-29c-3p and SPARC was intervened in C-33A and SiHa cells, RT-qPCR was used to detect the expression levels of miR-29c-3p and SPARC. Western blot was performed to observe the expression levels of SPARC and EMT-related proteins. The proliferation rate of C-33A and SiHa cells was measured using an MTT assay. The viability of the cells was determined using a cell colony formation assay. Apoptosis and cell cycle was measured using flow cytometry, and migration ability was observed using a wound healing assay. A transwell invasion assay was used to determine the invasion ability of the cells, whilst a dual-luciferase reporter assay verified that SPARC was a target gene of miR-29c-3p.RESULTS:miR-29c-3p was expressed at low levels in cervical cancer tissues and cells, while SPARC expression was upregulated. The luciferase reporter assay confirmed that miR-29c-3p targeted and bound to SPARC. MiR-29c-3p overexpression significantly inhibited the proliferation, invasion, migration, and cell cycle of cervical cancer cells, but promoted apoptosis. In the miR-29c-3p group (miR-29c-3p overexpression), EMT progression was inhibited by upregulating E-cadherin expression and downregulating N-cadherin, vimentin, and Snail expression, which was contrary to the results of the in-miR-29c-3p group (inhibition of miR-29c-3p expression). In the miR-29c-3p + SPARC group (miR-29c-3p overexpression + SPARC overexpression), the effect of miR-29c-3p overexpression on cervical cancer cell functions was reversed.CONCLUSIONS:miR-29c-3p can inhibit EMT by targeting SPARC, so as to inhibit the invasion and metastasis of cervical cancer cells.

A Regulatory Loop Involving Mir-29C and Sp1 Elevates the TGF-β1 Mediated Epithelial-to-mesenchymal Transition in Lung Cancer.

Mir-375 is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion Via Targeting Transcription Factor SP1

MicroRNA-182 Targets SMAD7 to Potentiate TGFβ-induced Epithelial-Mesenchymal Transition and Metastasis of Cancer Cells.

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Mir-335-5p Inhibits TGF-β1-induced Epithelial–mesenchymal Transition in Non-Small Cell Lung Cancer Via ROCK1

TGF-β1/miR-30d-5p axis regulating the expression of EMT key factors to induce apoptosis of lung cancer cells

Sp1 Suppresses Mir-3178 to Promote the Metastasis Invasion Cascade Via Upregulation of TRIOBP

Mir-29B Suppresses Proliferation, Migration, and Invasion of Tongue Squamous Cell Carcinoma Through PTEN-AKT Signaling Pathway by Targeting Sp1.

HIF1α-SP1 Interaction Disrupts the Circ-0001875/Mir-31-5p/sp1 Regulatory Loop under a Hypoxic Microenvironment and Promotes Non-Small Cell Lung Cancer Progression.

MiR-29 Mediates TGFβ 1-Induced Extracellular Matrix Synthesis Through Activation of Wnt/β -Catenin Pathway in Human Pulmonary Fibroblasts

MiR-326/Sp1/KLF3: A Novel Regulatory Axis in Lung Cancer Progression

Mir-32 Inhibits Proliferation, Epithelial-Mesenchymal Transition, and Metastasis by Targeting Twist1 in Non-Small-Cell Lung Cancer Cells

miR-29 mediates TGFβ1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts.

Overexpression of microRNA-611 inhibits TGF-β-induced epithelial-mesenchymal transition and migration in lung cancer cells through MAPKAP1

Hsa-Mir-329 Exerts Tumor Suppressor Function Through Down-Regulation Of Met In Non-Small Cell Lung Cancer

Mir-639 Regulates Transforming Growth Factor Beta-Induced Epithelial-Mesenchymal Transition in Human Tongue Cancer Cells by Targeting FOXC1.

miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma

P3.02-072 MiR-33b Inhibits Lung Adenocarcinoma Cell Epithelial-Mesenchymal Transition Through CeRNA Regulatory Network

Downregulation of Mir‐3127‐5p Promotes Epithelial‐mesenchymal Transition Via FZD4 Regulation of Wnt/β‐catenin Signaling in Non‐small‐cell Lung Cancer

A Regulatory Circuitry Comprising TP53, Mir-29 Family, and SETDB1 in Non-Small Cell Lung Cancer.

MiR-29c-3p Inhibits Epithelial-Mesenchymal Transition to Inhibit the Proliferation, Invasion and Metastasis of Cervical Cancer Cells by Targeting SPARC